UnitedHealth Group kicked off earnings season for the health insurance sector by reporting third-quarter results on October 28. The company posted adjusted earnings per share of $2.92, outpacing analyst forecasts by $0.05. Revenues rose 12.2% year-over-year to $113.16 billion, just shy of consensus estimates. Optum services revenue climbed 14.5%, driven by strong demand for pharmacy care services, while UnitedHealthcare segment revenue increased 10.8% as medical cost trends began to stabilize.

Investors have focused on UnitedHealth’s ability to rein in elevated medical cost trends that pressured margins over the past two years. Management reported that underlying medical cost trends moderated to 5.8% for the quarter, down from 7.2% in the year-earlier period. The company attributed the improvement to tighter network utilization management and targeted care coordination programs, which helped deliver a medical loss ratio of 82.1% versus 83.4% a year ago.

UnitedHealth Group declared a quarterly dividend of $2.21 per share, representing an 8% increase year-over-year and an annualized yield of approximately 2.7%. The December 16 payment date followed a mid-December record date, and the payout ratio now stands at 46.1% of trailing earnings. Management stated that robust free cash flow—totaling $12.4 billion year-to-date—supports both the dividend increase and ongoing share repurchases.

Hedge funds and institutional asset managers have collectively boosted their ownership in UnitedHealth stock over the past two quarters. Notably, North Capital Inc. raised its position by 16.2% to 194 shares, while Sunflower Bank N.A. increased its holding by 1.5% to 1,916 shares. Berkshire Hathaway also initiated a significant new stake valued at over $1.5 billion. Institutional ownership now represents nearly 88% of shares outstanding, underscoring confidence in UnitedHealth’s growth trajectory and margin improvement initiatives.